Skip to content

Agios Pharmaceuticals

US · AGIO #2841 by market cap Listed 1970
27.60 -1.16 -4.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Agios Pharmaceuticals

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Founded
2007
CEO
Mr. Brian Goff
Employees
540
Headquarters
Cambridge, Massachusetts, United States of America
Fiscal year end
12-31
Website
agios.com

Company profile

Exchange
US
Symbol
AGIO
Market-cap rank
#2841
Listing date
1970-01-01
Market cap
1.65B
Float cap
1.36B
Shares out
59.81M
Float shares
49.32M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Agios Pharmaceuticals discussion 0 comments

Add a comment